Oral Appliances Market Size & Growth Forecast 2027–2036, By Segments (Product, Indication, End Use, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Oral Appliances Market size was estimated at USD 1.07 billion in 2026 and is projected to grow at a 5.43% CAGR from 2027 to 2036, crossing USD 1.82 billion by 2036. The industry revenue for 2027 is calculated at USD 1.12 billion.

• Base Year Value (2026): USD 1.07 billion
• CAGR (2027-2036): 5.43%
• Forecast Year Value (2036): USD 1.82 billion
• Historical Data Period: 2022-2026
• Largest Region: Asia Pacific
• Forecast Period: 2027-2036

Oral Appliances Market Intelligence Snapshot:

• Regional Market Dynamics:

  • Asia Pacific leads the market due to its large patient base, strong demand across dental and sleep-related treatments, and broad product adoption through clinics and healthcare providers.
  • Asia Pacific is projected to expand at a 6.55% CAGR, driven by wider access to oral appliance treatments and increasing adoption across both established and developing healthcare settings.

• Segment Momentum:

  • Mandibular Advancement Devices (MADs) held a 66.93% share in 2026, supported by broad clinical familiarity, routine prescribing, and strong practitioner confidence in their fitting and adjustment.
  • Severe Obstructive Sleep Apnea (OSA) is the fastest-growing indication as providers increasingly consider oral appliances for patients requiring alternative treatment options based on tolerance, adherence, and individual therapeutic needs.

• Market Expansion Drivers:

  • Rising prevalence of obstructive sleep apnea increasing demand for non-invasive sleep therapies.
  • Advancements in comfortable mandibular advancement devices improving patient compliance and treatment adoption.
  • Expansion of telehealth sleep diagnostics supporting direct-to-consumer oral appliance adoption.

• Leading Market Participants:

  Prominent players in the oral appliances market include ResMed Inc. (United States), SomnoMed Limited (Australia), Glidewell Laboratories (United States), ProSomnus, Inc. (United States), Vivos Therapeutics, Inc. (United States), Apnea Sciences Corporation (United States), Signifier Medical Technologies Limited (United Kingdom), Mitsui Chemicals, Inc. (Japan), Airway Management, Inc. (United States), Whole You, Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 1.07 billion
  • 2027 Estimated Market Size: USD 1.12 billion.
  • Projected Market Size: USD 1.82 billion by 2036
  • Growth Forecasts: 5.43% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: Asia Pacific
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Mandibular Advancement Devices (MADs) (Product) | Mild to Moderate Obstructive Sleep Apnea (OSA) (Indication) | Homecare (End Use) | Hospitals & Clinics (Distribution Channel)
  • Emerging Opportunity Segment: Tongue Retaining Devices (TRDs) (Product) | Severe Obstructive Sleep Apnea (OSA) (Indication) | Homecare (End Use) | Direct-to-Consumer (Online and Offline) (Distribution Channel)

Market Growth Drivers and Industry Trends

Rising prevalence of obstructive sleep apnea increasing demand for non-invasive sleep therapies

Growing awareness of obstructive sleep apnea and its associated risks is strengthening demand for non-invasive treatment options, particularly among patients seeking alternatives to conventional therapies. The oral appliances market benefits from the increasing recognition of oral devices as a practical treatment approach for patients with appropriate forms of sleep-disordered breathing, as these devices can be used during sleep without requiring complex equipment. Greater screening for sleep apnea, improved understanding of its links with daytime fatigue and broader health complications, and rising willingness to pursue long-term treatment are encouraging more patients and healthcare providers to consider mandibular advancement and other oral appliance therapies.

Advancements in comfortable mandibular advancement devices improving patient compliance and treatment adoption

Technological improvements in device design are making mandibular advancement therapy more comfortable and easier to incorporate into patients' nighttime routines. In the oral appliances market, developments such as improved fit, personalized adjustment mechanisms, reduced bulk, and better compatibility with individual oral anatomy can address common concerns associated with discomfort and device retention. Enhanced comfort is particularly important for therapies that require consistent overnight use, as improved tolerability can encourage patients to continue treatment and increase acceptance among individuals who have difficulty adapting to other sleep therapy approaches.

Expansion of telehealth sleep diagnostics supporting direct-to-consumer oral appliance adoption

The growing use of telehealth is simplifying access to sleep-related evaluation and creating new pathways for patients to explore oral appliance treatment. Remote consultations, digital symptom assessments, and increasingly accessible sleep diagnostic services can reduce the need for repeated in-person visits during the initial stages of care. This shift can support oral appliances market growth by connecting patients with sleep specialists and treatment providers more conveniently, while digital care pathways also facilitate education, follow-up, device selection, and treatment monitoring for consumers seeking a less complex alternative to conventional sleep therapy.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of obstructive sleep apnea increasing demand for non-invasive sleep therapies	1.90%	Moderate	North America, Europe, Asia Pacific	High	Near Term
Advancements in comfortable mandibular advancement devices improving patient compliance and treatment adoption	1.60%	Moderate	North America, Europe	High	Mid Term
Expansion of telehealth sleep diagnostics supporting direct-to-consumer oral appliance adoption	1.30%	Low	North America, Asia Pacific	Emerging	Long Term

Regional Demand Dynamics

Asia Pacific (Largest & Fastest-Growing Region)

The oral appliances market was led by Asia Pacific, which held the largest share in 2026 while also representing the fastest-growing regional market. Its strong position is supported by rising awareness of oral health, expanding dental care access, and increasing adoption of minimally invasive treatment options for conditions such as sleep-related breathing disorders and orthodontic concerns. Growing healthcare expenditure, improving dental infrastructure, and the expansion of specialized clinics are strengthening the availability of oral appliance therapies across the region. At the same time, increasing urbanization, changing lifestyles, and greater recognition of preventive and restorative oral care are supporting sustained demand. Advances in appliance design, digital dentistry, and customized treatment approaches are further improving patient comfort and clinical outcomes, reinforcing the region's leadership and growth potential.

Key Country Insights

United States

Customized Sleep Solutions

The U.S. oral appliances market benefits from growing use of custom devices for obstructive sleep apnea and bruxism management. Healthcare providers in the U.S. increasingly collaborate across dental and sleep medicine practices to expand personalized treatment options.

Japan

Preventive Oral Care

Japan integrates oral appliances into preventive dental care and sleep disorder management. Japanese clinicians prioritize comfortable, durable devices that encourage consistent patient use while supporting minimally invasive treatment approaches.

South Korea

Digital Dentistry Adoption

South Korea advances the oral appliances market through digital dentistry, intraoral scanning, and customized device production. Korean dental clinics increasingly leverage digital workflows to improve appliance fit, treatment efficiency, and patient satisfaction.

Germany

Precision Dental Devices

Germany emphasizes high-quality oral appliances supported by advanced dental manufacturing and clinical precision. German dental professionals continue adopting customized solutions that improve patient comfort, treatment adherence, and long-term therapeutic effectiveness.

France

Multidisciplinary Treatment Approach

France promotes oral appliances through collaboration between dentists, orthodontists, and sleep specialists. French healthcare providers are expanding patient awareness and individualized treatment strategies that support effective management of sleep-related breathing disorders.

Italy

Restorative Care Integration

Italy incorporates oral appliances into restorative dentistry and sleep disorder treatment using patient-specific designs. Italian dental practices continue investing in modern fabrication techniques that enhance appliance performance while improving clinical workflow efficiency.

Segment Leadership and Growth Trends

 

Product Segment Analysis: Mandibular Advancement Devices (MADs) (Largest Segment) vs Tongue Retaining Devices (TRDs) (Fastest-Growing Segment)

Mandibular advancement devices (MADs) accounted for 66.93% share of the oral appliances market in 2026, reflecting their established role in the management of obstructive sleep apnea and related sleep-disordered breathing conditions. These appliances work by repositioning the lower jaw to help maintain airway patency during sleep and are valued for their non-invasive nature and suitability for patients seeking alternatives to more intensive treatment approaches. Growing awareness of sleep apnea, increasing diagnosis, and greater acceptance of oral appliance therapy continue to support demand for MADs.

Tongue retaining devices (TRDs) are gaining traction as interest grows in alternative oral appliance approaches for patients who may benefit from tongue-positioning therapy. These devices help maintain airway openness by positioning the tongue forward during sleep, offering a distinct mechanism from mandibular advancement. Greater awareness of personalized sleep-disorder management and expanding consideration of non-invasive treatment options are contributing to increasing adoption of TRDs.

Indication Segment Analysis: Mild to Moderate Obstructive Sleep Apnea (OSA) (Largest Segment) vs Severe Obstructive Sleep Apnea (OSA) (Fastest-Growing Segment)

The mild to moderate obstructive sleep apnea segment represented the largest share of the oral appliances market in 2026, supported by the suitability of oral appliances for patients seeking less invasive management of sleep-disordered breathing. Oral devices provide an alternative therapeutic approach for individuals who may not tolerate or prefer other treatment modalities. Increasing screening for sleep apnea, greater recognition of associated health risks, and broader availability of dental sleep medicine services continue to sustain demand within this indication.

Severe obstructive sleep apnea is gaining momentum as improvements in diagnosis and growing awareness encourage more patients with advanced disease to pursue treatment. While treatment decisions for severe cases depend on clinical assessment and individual patient needs, oral appliances can form part of a broader management strategy in selected patients. Greater emphasis on personalized care, improved awareness of untreated sleep apnea, and expanding access to specialized sleep services are supporting increased attention to this segment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Mandibular Advancement Devices (MADs), Tongue Retaining Devices (TRDs), Hybrid Devices	Mandibular Advancement Devices (MADs)	Tongue Retaining Devices (TRDs)
Indication	Mild to Moderate Obstructive Sleep Apnea (OSA), Severe Obstructive Sleep Apnea (OSA), Snoring	Mild to Moderate Obstructive Sleep Apnea (OSA)	Severe Obstructive Sleep Apnea (OSA)
End Use	Homecare, Hospitals & Clinics, Others	Homecare	Homecare
Distribution Channel	Direct-to-Consumer (Online and Offline), Hospitals & Clinics, Others	Hospitals & Clinics	Direct-to-Consumer (Online and Offline)

Competitive Landscape and Market Positioning

Leading companies in the oral appliances market:

1. ResMed Inc. (United States)

2. SomnoMed Limited (Australia)

3. Glidewell Laboratories (United States)

4. ProSomnus Inc. (United States)

5. Vivos Therapeutics Inc. (United States)

6. Apnea Sciences Corporation (United States)

7. Signifier Medical Technologies Limited (United Kingdom)

8. Mitsui Chemicals Inc. (Japan)

9. Airway Management Inc. (United States)

10. Whole You Inc. (United States)

In the oral appliances market, growing focus on sleep and dental disorder management is driving demand for more comfortable and effective treatment devices. Continuous product refinement is enhancing fit, usability, and therapeutic performance. Differentiation is increasingly achieved through patient-centric design improvements and adaptive functionality.

Industry Development/News

Company Name	Date	Key Development
Vivos Therapeutics	Jan-24	The company secured regulatory clearance for an oral appliance specifically indicated for severe obstructive sleep apnea. This development marks a significant shift in clinical scope for oral appliance therapy, enabling treatment for more severe patient segments and enhancing the company’s competitive position in the sleep medicine market.
ProSomnus	Jan-24	The company announced compliance with updated UnitedHealthcare medical policy, which mandates oral appliance therapy as a prerequisite for more invasive treatments like hypoglossal nerve stimulation. This regulatory alignment significantly improves market access and establishes a formal clinical pathway for Precision OAT devices in patients with moderate to severe obstructive sleep apnea.
Glidewell	May-23	Glidewell acquired ORB Innovations Limited to accelerate the development of smart oral appliance technology. This strategic acquisition positions the company to integrate sensor-based capabilities into its sleep therapy portfolio, aiming to evolve standard oral appliances into intelligent wellness-monitoring devices for broader dental and health applications.
Apex Dental Sleep Lab	Apr-26	The company secured Medicare E0486 approval for its Kava Herbst 3D oral appliance. This regulatory milestone for the resin-printed device facilitates broader insurance reimbursement and accelerates market adoption among practitioners, reflecting the ongoing industry transition toward 3D-printed, digitally-driven oral appliance solutions for mild to moderate obstructive sleep apnea.
MellingMedical	May-26	MellingMedical entered a strategic partnership with TAP Sleep Care to supply oral appliance therapy solutions to federal healthcare providers. This collaboration expands the distribution network for sleep apnea treatments, specifically improving access for veterans and active-duty military personnel through established federal procurement channels.
IAOS	May-25	IAOS completed a merger with Restfull, integrating dental sleep medicine coaching with specialized billing and practice management software. This consolidation aims to optimize reimbursement workflows and improve operational efficiency for clinical providers, addressing a critical bottleneck in the commercial delivery of oral appliance therapy.
LuxCreo	Oct-24	LuxCreo partnered with EMA Sleep to scale manufacturing and enable same-day production of 3D-printed oral appliances. By optimizing the supply chain and localizing manufacturing capabilities, the partnership addresses the growing demand for rapid fulfillment and technologically advanced, patient-specific sleep apnea solutions.
Vivos Therapeutics	Mar-26	Vivos Therapeutics expanded its sleep healthcare network by securing in-network status with major commercial insurers and Medicare for affiliated practices in Nevada. This expansion of the provider network directly enhances patient access to the company's sleep apnea treatment offerings and strengthens its commercial footprint.
Good Sleep Co	Nov-25	The company obtained FDA clearance for the Hushd Pro Z-Link, a modular nylon mandibular advancement device. The clearance of this customizable appliance introduces a flexible treatment option for snoring and sleep apnea, contributing to the competitive landscape of standardized, yet adjustable, oral appliance solutions.
Sleep Doctor	Feb-24	Sleep Doctor entered a partnership with Airway Management to offer the myTAP oral appliance. This collaboration leverages an established, FDA-cleared therapy solution to provide a cost-effective and convenient clinical option, supporting broader commercial scalability for non-invasive sleep apnea treatments.